• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    EVP & Chief Mfg and Supply Cha Brosius Mark sold $23,464 worth of shares (54 units at $434.52) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,559 units (SEC Form 4)

    5/20/26 6:02:58 PM ET
    $ISRG
    Industrial Specialties
    Health Care
    Get the next $ISRG alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Brosius Mark

    (Last)(First)(Middle)
    1020 KIFER ROAD

    (Street)
    SUNNYVALE CALIFORNIA 94086

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    INTUITIVE SURGICAL INC [ ISRG ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director10% Owner
    XOfficer (give title below)Other (specify below)
    EVP & Chief Mfg and Supply Cha
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    05/18/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Common Stock05/18/2026S(1)18D$422.471,595D
    Common Stock05/19/2026S(1)18D$440.71,577D
    Common Stock05/20/2026S(1)18D$440.381,559D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.
    By: Stephanie Lim-Ignacio For: Brosius, Mark05/20/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $ISRG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ISRG

    DatePrice TargetRatingAnalyst
    3/11/2026$590.00Neutral → Buy
    Citigroup
    1/27/2026$660.00Buy
    TD Cowen
    12/11/2025$635.00Buy → Neutral
    Citigroup
    7/23/2025Buy → Hold
    Erste Group
    6/9/2025$440.00Hold → Sell
    Deutsche Bank
    6/5/2025Hold → Buy
    Erste Group
    12/2/2024$522.00 → $650.00Equal-Weight → Overweight
    Morgan Stanley
    8/2/2024$380.00 → $510.00Neutral → Buy
    Redburn Atlantic
    More analyst ratings

    $ISRG
    SEC Filings

    View All

    Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

    5/28/26 4:35:49 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    SEC Form SD filed by Intuitive Surgical Inc.

    SD - INTUITIVE SURGICAL INC (0001035267) (Filer)

    5/21/26 4:10:02 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

    5/4/26 4:05:32 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton

    SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of Global Senior Vice President of Intuitive's endoluminal business Taylor Patton to Chief Commercial and Marketing Officer, effective July 1. Patton will join Intuitive's Executive Leadership team and succeed Henry Charlton, who will assume the role of Senior Vice President of Global Business Operations. Charlton will work closely with Patton to support a smooth transition advancing Intuitive's global impact and excellence in support of customers and their work to expand access to mini

    5/28/26 4:30:00 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces Innovations to Advance Quintuple Aim

    SUNNYVALE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced several recent and upcoming innovations, including enhancements across da Vinci 5 and its supporting ecosystem, extended‑use Force Feedback instruments, and advancements designed to enhance product and instrument security and reliability. "Intuitive is guided by a commitment to helping our customers achieve the Quintuple Aim: improving patient care and outcomes, optimizing surgeon and care team experience, and expanding access to minimally invasive care while lowering the total cost of care," said In

    5/21/26 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces First Quarter Earnings

    SUNNYVALE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2026. Q1 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 17% compared with the first quarter of 2025. Da Vinci procedures grew approximately 16%, and Ion procedures grew approximately 39%.The Company placed 431 da Vinci surgical systems, compared with 367 in the first quarter of 2025. The first quarter 2026 da Vinci surgical system placements included 232 da Vinci 5 systems, compared with 147 in the fi

    4/21/26 4:38:28 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & GM da Vinci Platforms & Jeddi Iman sold $2,365,594 worth of shares (5,625 units at $420.55) as part of a pre-agreed trading plan and exercised 5,625 shares at a strike of $77.00 (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    6/2/26 10:08:13 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    EVP & Chief Mfg and Supply Cha Brosius Mark sold $15,945 worth of shares (36 units at $442.92) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,523 units (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    5/22/26 8:09:35 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    EVP & Chief Mfg and Supply Cha Brosius Mark sold $23,464 worth of shares (54 units at $434.52) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,559 units (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    5/20/26 6:02:58 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Intuitive Surgical upgraded by Citigroup with a new price target

    Citigroup upgraded Intuitive Surgical from Neutral to Buy and set a new price target of $590.00

    3/11/26 8:28:54 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    TD Cowen initiated coverage on Intuitive Surgical with a new price target

    TD Cowen initiated coverage of Intuitive Surgical with a rating of Buy and set a new price target of $660.00

    1/27/26 8:46:58 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Surgical downgraded by Citigroup with a new price target

    Citigroup downgraded Intuitive Surgical from Buy to Neutral and set a new price target of $635.00

    12/11/25 8:53:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Financials

    Live finance-specific insights

    View All

    Intuitive Announces First Quarter Earnings

    SUNNYVALE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2026. Q1 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 17% compared with the first quarter of 2025. Da Vinci procedures grew approximately 16%, and Ion procedures grew approximately 39%.The Company placed 431 da Vinci surgical systems, compared with 367 in the first quarter of 2025. The first quarter 2026 da Vinci surgical system placements included 232 da Vinci 5 systems, compared with 147 in the fi

    4/21/26 4:38:28 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces Fourth Quarter Earnings

    SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%.The Company placed 532 da Vinci surgical systems, compared with 493 in the fourth quarter of 2024. The fourth quarter 2025 da Vinci surgical system placements included 303 da Vinci 5 systems, compared with 174 i

    1/22/26 4:05:00 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results

    SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. Financial and Operational Highlights Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%. Average da Vinci system utilization increased 4%

    1/14/26 9:05:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Leadership Updates

    Live Leadership Updates

    View All

    Intel Appoints Dr. Craig H. Barratt to Board of Directors

    Intel Corporation (NASDAQ:INTC) today announced that Craig H. Barratt, Ph.D., 63, has been appointed to its board of directors, effective immediately. Dr. Barratt will serve as an independent director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110908011/en/Dr. Craig H. Barratt joins Intel's board as an independent director. "Craig is a highly accomplished technology leader with a proven ability to innovate, scale, and transform businesses," said Lip-Bu Tan, Intel CEO. "He is a seasoned semiconductor executive with experience at multiple leading-edge technology companies, which will be invaluable as we continue to execute

    11/10/25 6:21:00 PM ET
    $ALAB
    $INTC
    $ISRG
    Semiconductors
    Technology
    Industrial Specialties
    Health Care

    30 years of Innovation and Impact: Dan Larson's Inspiring Story

    SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuit

    5/27/25 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces CEO Transition Effective July 1, 2025

    President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t

    5/15/25 9:05:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    2/14/24 10:02:59 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    2/14/23 12:37:59 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    2/9/23 11:22:22 AM ET
    $ISRG
    Industrial Specialties
    Health Care